Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 8/20 | 0.75 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.75 |
| ▸ | CYP3A4 | P08684 | 8/20 | 0.75 |
| ▸ | MAPT | P10636 | 7/20 | 0.75 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.75 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.75 |
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.75 |
| ▸ | HPGD | P15428 | 5/20 | 0.75 |
| ▸ | THRB | P10828 | 3/20 | 0.75 |
| ▸ | RECQL | P46063 | 3/20 | 0.75 |
| ▸ | USP2 | O75604 | 3/20 | 0.75 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.75 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.75 |
| ▸ | CDK2 | P24941 | 1/20 | 0.75 |
| ▸ | APEX1 | P27695 | 1/20 | 0.75 |
| ▸ | PHPT1 | Q9NRX4 | 2/20 | 0.51 |
| ▸ | CASP1 | P29466 | 2/20 | 0.51 |
| ▸ | SLCO1B3 | Q9NPD5 | 2/20 | 0.51 |
| ▸ | SLCO1B1 | Q9Y6L6 | 2/20 | 0.51 |
| ▸ | MED25 | Q71SY5 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2115715 | 0.92 | ALDH1A1 (0.66) | MEN1KMT2ACYP3A4MAPTALDH1A1 | |
| SCHEMBL2113668 | 0.91 | CYP3A4 (0.62) | MEN1KMT2ACYP3A4MAPTALDH1A1 | |
| SCHEMBL2112577 | 0.90 | MEN1 (0.61) | MEN1KMT2ACYP3A4MAPTALDH1A1 | |
| SCHEMBL2114347 | 0.90 | CYP3A4 (0.61) | MEN1KMT2ACYP3A4MAPTALDH1A1 | |
| SCHEMBL2114717 | 0.90 | CYP3A4 (0.61) | MEN1KMT2ACYP3A4MAPTALDH1A1 | |
| SCHEMBL2618037 | 0.89 | MAPT (0.59) | MEN1KMT2ACYP3A4MAPTALDH1A1 | |
| SCHEMBL2113989 | 0.89 | CYP3A4 (0.61) | MEN1KMT2ACYP3A4MAPTALDH1A1 | |
| SCHEMBL2112251 | 0.88 | ALDH1A1 (0.62) | MEN1KMT2ACYP3A4MAPTALDH1A1 | |
| SCHEMBL17988248 | 0.87 | MAPT (0.72) | MEN1KMT2ACYP3A4MAPTALDH1A1 | |
| SCHEMBL2112791 | 0.87 | MEN1 (0.60) | MEN1KMT2ACYP3A4MAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260114475-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2026-04-30 | — | — | US | disclosed |
| EP-4593631-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | Mars, Incorporated (US) | 2025-08-06 | — | — | EP | disclosed |
| CN-119639835-A | Preparation method of keemun camellia seed fermented oil | 广州中妆美业化妆品有限公司 | 2025-03-18 | — | — | CN | disclosed |
| WO-2024073025-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2024-04-04 | — | — | WO | disclosed |
| EP-4344552-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2024-04-03 | — | — | EP | disclosed |
| CN-112135599-B | Skin whitening agent | 宝丽化成工业有限公司 | 2023-03-31 | — | — | CN | disclosed |
| WO-2022211646-A1 | GLOBULE COMPRISING CETRARIA ISLANDICA THALLUS EXTRACT AND THE METHOD OF ITS PREPARATION | MASTER PHARM S.A. (PL) | 2022-10-06 | — | — | WO | disclosed |
| US-20210346385-A1 | TASTE-MASKED DOSAGE FORMS | DEEP OCEAN CAPITAL MANAGEMENT LP | 2021-11-11 | — | — | US | disclosed |
| WO-2020061584-A1 | TASTE-MASKED DOSAGE FORMS | MSB HOLDINGS, INC. (US) | 2020-03-26 | — | — | WO | disclosed |
| US-20190054186-A1 | Magnetic Nanoparticle-Polymer Complexes and uses Thereof | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2019-02-21 | — | — | US | disclosed |
| EP-1109539-A1 | NANOGEL NETWORKS AND BIOLOGICAL AGENT COMPOSITION THEREOF | SUPRATEK PHARMA, INC. (CA) | 2001-06-27 | — | — | EP | disclosed |
| EP-1005324-A4 | COMPOSITIONS FOR DELIVERY OF BIOLOGICAL AGENTS AND METHODS FOR THE PREPARATION THEREOF | UNIV NEBRASKA (US) | 2001-06-06 | — | — | EP | disclosed |
| US-6143413-A | Magnetic recording medium and head cleaning tape | SONY CORPORATION (JP) | 2000-11-07 | — | — | US | disclosed |
| EP-1005324-A1 | COMPOSITIONS FOR DELIVERY OF BIOLOGICAL AGENTS AND METHODS FOR THE PREPARATION THEREOF | UNIVERSITY OF NEBRASKA BOARD OF REGENTS (US) | 2000-06-07 | — | — | EP | disclosed |
| WO-2000013677-A1 | NANOGEL NETWORKS AND BIOLOGICAL AGENT COMPOSITION THEREOF | SUPRATEK PHARMA, INC. (CA) | 2000-03-16 | — | — | WO | disclosed |
| WO-1998056348-A1 | COMPOSITIONS FOR DELIVERY OF BIOLOGICAL AGENTS AND METHODS FOR THE PREPARATION THEREOF | UNIVERSITY OF NEBRASKA BOARD OF REGENTS (US) | 1998-12-17 | — | — | WO | disclosed |
| WO-1998056334-A1 | COMPOSITIONS FOR DELIVERY OF BIOLOGICAL AGENTS AND METHODS FOR THE PREPARATION THEREOF | UNIVERSITY OF NEBRASKA BOARD OF REGENTS (US) | 1998-12-17 | — | — | WO | disclosed |
| CN-1180218-A | Magnetic recording medium and cleaning tape | SONY CORP (JP) | 1998-04-29 | — | — | CN | disclosed |
| EP-0827135-A1 | Magnetic recording medium and cleaning tape | SONY CORPORATION (JP) | 1998-03-04 | — | — | EP | disclosed |
| US-4536474-A | SYMBIOTIC MIXTURE OF ALGAE AND FUNGI | NIPPON PAINT CO., LTD. (JP) | 1985-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260114475-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | PIGS, TAS2R13, CEL | MEN1 3411/4885KMT2A 1142/4885CYP3A4 3591/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.